Rapid Micro Biosystems, Inc.
HealthcareNASDAQ:RPID · NASDAQ Global Select
-$0.12 today
Vol 0.14M · Avg 0.20M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-141.9%
avg 350.3%
ROIC
-82.2%
avg -55.7%
ROA
-63.0%
avg -47.1%
Analysis
ROA is currently the strongest return metric at -63.0% versus its period average of -47.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Robert G. Spignesi Jr. | CEO, President, COO & Director | $1.19M | — | 56 | $1.19M | 2.63% |
Sean Wirtjes | Chief Financial Officer | $711,210.00 | — | 57 | $568,981.00 | 1.26% |
Julie Jarvie | Senior Vice President of Human Resources | — | — | — | — | — |
Katherine Atkinson | Senior VP of Global Sales & Marketing | — | — | — | — | — |
James Xu | Senior Vice President of Legal & Secretary | — | — | — | — | — |
Michael Beaulieu | Vice President of Investor Relations & Corporate Communications | — | — | — | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
3
$6.30M
Sells
19
$1.33M
Net Sentiment
+$4.96M
Net buying
Most Active
Spignesi Robert G. Jr.
8 transactions
1–10 of 22
Analysis
Insiders reported 3 buys worth $6.30M and 19 sells worth $1.33M over the last 12 months. That adds up to net buying of $4.96M. Spignesi Robert G. Jr. was the most active insider with 8 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +11.9% | +22.1% (6yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +11.9% over three years. Forward estimates point to Revenue at +22.1% (6yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Apyx Medical Corporation
NASDAQ:APYX
$196.39M
Lucid Diagnostics Inc.
NASDAQ:LUCD
$98.28M
AVITA Medical, Inc.
NASDAQ:RCEL
$97.14M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$89.03M
Owlet, Inc.
NYSE:OWLT
$84.14M
Sera Prognostics, Inc.
NASDAQ:SERA
$71.42M
LENSAR, Inc.
NASDAQ:LNSR
$70.45M
Vivani Medical, Inc.
NASDAQ:VANI
$64.99M
Tevogen Bio Holdings Inc.
TVGN
$43.84M
InspireMD, Inc.
NSPR
$34.19M
Who manages RPID?
Rapid Micro Biosystems, Inc. (RPID) lists 6 active executives. The top listed executive is Robert G. Spignesi Jr., CEO, President, COO & Director.
Are RPID insiders buying or selling?
Recent insider activity shows net buying of $15.63M.
Explore More
Continue the stock analysis
Jump to another research area for this company.